Patents Assigned to Illumina
  • Patent number: 12062419
    Abstract: A system writes input data to a storage device as machine-written polynucleotides; and reads machine written polynucleotides from the storage device as output data. The storage device includes a flow cell including a plurality of storage wells in which machine written polynucleotides may be stored. The storage device may include a set of electrodes corresponding to the storage wells that allow for selective interactions with wells across the surface of a flow cell. Operation of the storage device may include receiving a read request associated with a particular location in the storage device, creating a copy of a nucleotide sequence located at the particular location in the storage device, transferring the copy of the nucleotide sequence to a read location, and reading the copy of the nucleotide sequence at the read location.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: August 13, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Craig Ciesla, Ali Agah, Stanley Hong, Tarun Khurana, Aathavan Karunakaran, Arvin Emadi, Merek Siu
  • Publication number: 20240263229
    Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing.
    Type: Application
    Filed: December 15, 2022
    Publication date: August 8, 2024
    Applicant: Illumina, Inc.
    Inventors: Xiaoyu Ma, Mathieu Lessard-Viger, Jeffrey Fisher, Jonathan Boutell
  • Publication number: 20240263164
    Abstract: The present disclosure is related to methods and materials for depleting unwanted RNA species from a nucleic acid sample. In particular, the present disclosure describes how to remove unwanted rRNA, tRNA, mRNA or other RNA species that could interfere with the analysis, manipulation and study of target RNA molecules in a sample.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 8, 2024
    Applicant: Illumina, Inc.
    Inventors: Scott Kuersten, Frederick W. Hyde, Asako Tetsubayashi
  • Patent number: 12054712
    Abstract: Methods and systems are provided for differentiating between cancer variants and somatic variants originating from hematopoietic cells in a cell free DNA sample. In some embodiments, the cancer variants can be distinguished from somatic variants originating from hematopoietic cells based on fragment size distribution.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: August 6, 2024
    Assignee: ILLUMINA, INC.
    Inventor: Tingting Jiang
  • Patent number: 12053776
    Abstract: For example, a flowcell includes: a nanowell layer having a first set of nanowells and a second set of nanowells to receive a sample; a first linear waveguide associated with the first set of nanowells, and a second linear waveguide associated with the second set of nanowells; and a first grating for the first linear waveguide, and a second grating for the second linear waveguide, the first and second gratings providing differential coupling of first light and second light.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: August 6, 2024
    Assignees: ILLUMINA CAMBRIDGE LIMITED, ILLUMINA, INC.
    Inventors: Geraint Evans, Stanley S. Hong
  • Patent number: 12058129
    Abstract: Policy-based genomic digital data sharing facilitates a variety of sharing scenarios, including public access, tenant-to-tenant sharing, workgroup sharing, and access by external service providers. Genomic digital data can be published to the platform and controlled by access tokens that are generated based on access policies. The policies can support conditions that are evaluated at execution time and effectively place control of access to information in hands of the owning tenant. Sharing conditions can be easily specified to support various use cases, relieving administrators from excessive access control configuration.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: August 6, 2024
    Assignee: Illumina, Inc.
    Inventors: Prabhu Palanisamy, Milan Karangutkar, Ryan Stinson
  • Publication number: 20240257320
    Abstract: Systems, methods, and apparatuses are described herein. For instance, a detection apparatus may comprise memory and at least one processor. The detection apparatus may be configured to obtain an image comprising at least one feature and a plurality of fiducials. The plurality of fiducials may be arranged in a pattern. The detection apparatus may be configured to determine a plurality of sub-regions of the image. Each sub-region comprises a subset of the fiducials comprised in the image. The detection apparatus may be configured to perform a geometric transform on each sub-region to generate a respective local transform associated with each sub-region. The detection apparatus may be configured to register respective locations of the fiducials comprised in the image based on the respective local transform associated with each sub-region. A size of each sub-region may be selected such that each sub-region is substantially invariant to stage jitter.
    Type: Application
    Filed: January 5, 2024
    Publication date: August 1, 2024
    Applicant: Illumina, Inc.
    Inventors: Robert Ezra Langlois, Hongji Ren, Mohamed Khaled Mohamed Geunady, John S. Vieceli, Gregory Holst, Paul Sangiorgio
  • Publication number: 20240257904
    Abstract: Improved copy number variant (CNV) calling in a genomic sequence, and potential recovery, includes (i) obtaining genetic sequence variant data that includes records indicating structural variant(s) (SVs) and records indicating CNV(s) in the genomic sequence, (ii) determining, based on an initial CNV indicated in the genetic sequence variant data and on initial SV(s) indicated in the genetic sequence variant data, an SV-informed CNV call as an updated version of the initial CNV, where the determining uses information from the initial SV(s) to determine a start breakpoint position and an end breakpoint position for the SV-informed CNV call, at least one of the start breakpoint position and end breakpoint position being updated, informed by the initial SV(s), in comparison to a corresponding start breakpoint position and/or end breakpoint position of the initial CNV, and (ii) writing the determined SV-informed CNV call as record(s) in a genetic sequence variant data file.
    Type: Application
    Filed: January 24, 2024
    Publication date: August 1, 2024
    Applicant: Illumina, Inc.
    Inventors: Eric Roller, Aaron Halpern, Sean Truong
  • Patent number: 12050194
    Abstract: In an example, a sensing system includes a pH sensor. The pH sensor includes two electrodes and a conductive channel operatively connected to the two electrodes. A complex is attached to the conductive channel of the pH sensor. The complex includes a polymerase linked to at least one pH altering moiety that is to participate in generating a pH change within proximity of the conductive channel from consumption of a secondary substrate in a fluid that is exposed to the pH sensor. The at least one pH altering moiety is selected from the group consisting of an enzyme, a metal coordination complex, a co-factor, and an activator.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: July 30, 2024
    Assignee: Illumina, Inc.
    Inventors: Jeffrey S. Fisher, Brian D. Mather, Kaitlin M. Pugliese, Jeffrey G. Mandell, Maria Candelaria Rogert Bacigalupo, Boyan Boyanov
  • Patent number: 12048928
    Abstract: A flow cell including inlet and outlet ports in fluid communication with each other through a flow channel that extends therebetween. The flow channel includes a diffuser region and a field region that is located downstream from the diffuser region. The field region of the flow channel directs fluid along reaction sites where desired reactions occur. The fluid flows through the diffuser region in a first flow direction and through the field region in a second flow direction. The first and second flow directions being substantially perpendicular.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: July 30, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Helmy A. Eltoukhy, Tarun Khurana, Behnam Javanmardi, Poorya Sabounchi, Majid Aghababazadeh
  • Publication number: 20240247254
    Abstract: Embodiments of the present invention relate to analyzing components of a cell. In some embodiments, the present invention relate to analyzing components of a single cell. In some embodiments, the methods and compositions relate to sequencing nucleic acids. In some embodiments, the methods and compositions relate to identifying and/or quantitating nucleic acid, proteins, organelles, and/or cellular metabolites.
    Type: Application
    Filed: April 8, 2024
    Publication date: July 25, 2024
    Applicant: ILLUMINA, INC.
    Inventors: Kevin L. Gunderson, Frank J. Steemers, Jeffrey S. Fisher, Roberto Rigatti
  • Patent number: 12043637
    Abstract: The present application relates to substituted dyes containing bis-boron fused heterocycles and their uses as fluorescent labels. These compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: July 23, 2024
    Assignee: Illumina Cambridge Limited
    Inventors: Michael Callingham, Nikolai Nikolaevich Romanov, Xiaohai Liu, Justyna Piekos
  • Patent number: 12044624
    Abstract: A system includes: an objective lens; a first light source to feed first illuminating light through the objective lens and into a flowcell (e.g., with a relatively thin film waveguide) to be installed in the system, the first illuminating light to be fed using a first grating on the flowcell; and a first image sensor to capture imaging light using the objective lens, wherein the first grating is positioned outside a field of view of the first image sensor. Dual-surface imaging can be performed. Flowcells with multiple swaths bounded by gratings can be used. An auto-alignment process can be performed.
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: July 23, 2024
    Assignee: Illumina, Inc.
    Inventors: Yinghua Sun, Stanley S. Hong, Frederick Erie, Alex Nemiroski, M. Shane Bowen, Danilo Condello, Dietrich Dehlinger, Marco A. Krumbuegel, Anthony Lam, Aaron Liu, Bojan Obradovic, Mark Pratt
  • Patent number: 12044626
    Abstract: A system includes a plurality of modular subassemblies and a plate; wherein each modular subassembly comprises an enclosure and a plurality of optical components aligned to the enclosure, and each enclosure comprises a plurality of mounting structures; and wherein each modular subassembly is mechanically coupled to the plate by attachment of a mounting structure of the modular subassembly directly to a corresponding mounting structure located on the plate, such that by mechanically coupling each modular subassembly to the plate using the mounting structure of the modular subassembly and the corresponding mounting structure on the plate, adjacent modular subassemblies are aligned to each other upon such attachment, and wherein two of the modular subassemblies mechanically coupled to the plate are also attached to each other by mechanically coupling an alignment structure on one of the two modular subassemblies to a respective alignment structure on the other of the two modular subassemblies.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: July 23, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Wenyi Feng, Simon Prince, Peter Clarke Newman, Dakota Watson, Stanley S. Hong, Marco A. Krumbuegel, Yinghua Sun, Andrew James Carson, Merek C. Siu
  • Publication number: 20240240243
    Abstract: A composition for amplifying a polynucleotide is provided that includes a substrate comprising a first region and a second region. A first plurality of capture primers is coupled to the first region of the substrate. A second plurality of capture primers is coupled to the second region of the substrate. The capture primers of the second plurality of capture primers are longer than the capture primers of the first plurality of capture primers. A first plurality of orthogonal capture primers are coupled to the first region of the substrate. A second plurality of orthogonal capture primers are coupled to the second region of the substrate. The orthogonal capture primers of the second plurality of orthogonal capture primers are shorter than the orthogonal capture primers of the first plurality of orthogonal capture primers.
    Type: Application
    Filed: January 22, 2024
    Publication date: July 18, 2024
    Applicants: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Jeffrey Fisher, Jason Betley
  • Patent number: 12040047
    Abstract: Presented herein are techniques for identifying and/or validating sequence variants in genomic sequence data. The techniques include generating an error rate reflective of sequence errors present in the genomic sequence data. The error rate may be used to validate potential sequence variants. The error rate may be based on errors identified during consensus sequence confirmation for sequence reads associated with individual unique molecular identifiers.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: July 16, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Tingting Jiang, Chen Zhao
  • Patent number: 12031178
    Abstract: Embodiments of the present disclosure relate to cyclooctatetraene containing dyes and their uses as fluorescent labels. Also provided are composition containing cyclooctatetraene. The dyes and compositions may be used in various biological applications, such as nucleic acid sequencing.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: July 9, 2024
    Assignee: Illumina Cambridge Limited
    Inventors: Xiaolin Wu, Xiaohai Liu, Nikolai Nikolaevich Romanov, Antoine Francais, Patrick McCauley, Michael Callingham, Carole Anastasi
  • Patent number: 12031181
    Abstract: Provided herein are systems and methods for quantitating the HLA diversity in a solid tissue or circulating tumor DNA sample that is predictive of a patient's responsiveness to immune checkpoint inhibitory therapies.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: July 9, 2024
    Assignee: ILLUMINA, INC.
    Inventors: Bochao Zhang, Shile Zhang
  • Publication number: 20240218423
    Abstract: This application relates to methods of denaturing double-stranded DNA (dsDNA). In some examples, the methods utilize dried sodium hydroxide. In some examples, the method includes loading dsDNA into a first portion of a cartridge, wherein the second portion of the cartridge contains sodium hydroxide in a dry form; and mixing the dsDNA with the sodium hydroxide, thereby denaturing the dsDNA.
    Type: Application
    Filed: December 20, 2023
    Publication date: July 4, 2024
    Applicant: Illumina, Inc.
    Inventors: Eli Carrami, Oliver Miller, Sebastien Ricoult, Eilidh Rivers, Dale Weekes
  • Publication number: 20240209419
    Abstract: Methods for on-flow cell selective capture and enrichment of clustered beads, general capture strategies on bead mobility on flow cell surfaces, sorting clustered and unclustered beads, and flow cell reusability for bead immobilization onto flow cells.
    Type: Application
    Filed: December 14, 2023
    Publication date: June 27, 2024
    Applicant: Illumina, Inc.
    Inventors: Naneki McCallum, Fei Shen, Xiaoyu Ma, Weixian Xi, Olivia Ghazinejad, Jeffrey Brodin, Jeff Fisher